FI62103C - Foerfarande foer framstaellning av heparin med hoeg specifik aktivitet - Google Patents
Foerfarande foer framstaellning av heparin med hoeg specifik aktivitet Download PDFInfo
- Publication number
- FI62103C FI62103C FI770491A FI770491A FI62103C FI 62103 C FI62103 C FI 62103C FI 770491 A FI770491 A FI 770491A FI 770491 A FI770491 A FI 770491A FI 62103 C FI62103 C FI 62103C
- Authority
- FI
- Finland
- Prior art keywords
- heparin
- gel
- requirement
- requirements
- specific activities
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title description 41
- 229920000669 heparin Polymers 0.000 title description 41
- 229960002897 heparin Drugs 0.000 title description 41
- 230000000694 effects Effects 0.000 title description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000004019 antithrombin Substances 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000007983 Tris buffer Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000002523 gelfiltration Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940122618 Trypsin inhibitor Drugs 0.000 description 3
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- KKNIUBFRGPFELP-UHFFFAOYSA-N secretolin Chemical compound N=1C=CNC=1CC(N)C(=O)NC(CO)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(O)=O)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(O)=O)C(C)O)CC1=CC=CC=C1 KKNIUBFRGPFELP-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000002753 trypsin inhibitor Substances 0.000 description 3
- 102000013831 Coagulation factor IX Human genes 0.000 description 2
- 108090000056 Complement factor B Proteins 0.000 description 2
- 102000003712 Complement factor B Human genes 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 229940105774 coagulation factor ix Drugs 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000002565 heparin fraction Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 102100030009 Azurocidin Human genes 0.000 description 1
- 101710154607 Azurocidin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 102000022382 heparin binding proteins Human genes 0.000 description 1
- 108091012216 heparin binding proteins Proteins 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7603040 | 1976-03-05 | ||
| SE7603040A SE431218B (sv) | 1976-03-05 | 1976-03-05 | Forfarande for rening av heparin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI770491A7 FI770491A7 (cs) | 1977-09-06 |
| FI62103B FI62103B (fi) | 1982-07-30 |
| FI62103C true FI62103C (fi) | 1982-11-10 |
Family
ID=20327240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI770491A FI62103C (fi) | 1976-03-05 | 1977-02-15 | Foerfarande foer framstaellning av heparin med hoeg specifik aktivitet |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS52108012A (cs) |
| AT (1) | AT356818B (cs) |
| AU (1) | AU508430B2 (cs) |
| CA (1) | CA1079272A (cs) |
| CS (1) | CS196349B2 (cs) |
| DE (1) | DE2709500C2 (cs) |
| DK (1) | DK155606C (cs) |
| ES (1) | ES456196A1 (cs) |
| FI (1) | FI62103C (cs) |
| FR (1) | FR2342991A1 (cs) |
| GB (1) | GB1539332A (cs) |
| HU (1) | HU176811B (cs) |
| IE (1) | IE44907B1 (cs) |
| IL (1) | IL51346A (cs) |
| NL (1) | NL186385C (cs) |
| NO (1) | NO144388C (cs) |
| NZ (1) | NZ183480A (cs) |
| PL (1) | PL103049B1 (cs) |
| SE (1) | SE431218B (cs) |
| SU (1) | SU736860A3 (cs) |
| ZA (1) | ZA771267B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE449753B (sv) * | 1978-11-06 | 1987-05-18 | Choay Sa | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
| DE3531101A1 (de) * | 1984-08-31 | 1986-03-13 | Nicolás Huberto Olivos Behrens | Ein nicht thrombenbildendes heparin und ein verfahren zu seiner gewinnung |
| US9676816B2 (en) * | 2014-01-21 | 2017-06-13 | Board Of Trustees Of The University Of Arkansas | Heparin affinity tag and applications thereof |
| CN119039480A (zh) * | 2024-11-01 | 2024-11-29 | 山东万邦赛诺康生化制药股份有限公司 | 一种肝素钠酶解精制方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2623001A (en) * | 1949-04-07 | 1952-12-23 | Bengt E G V Sylven | Preparing heparin |
| DE1195010B (de) * | 1962-05-12 | 1965-06-16 | Ormonoterapia Richter S P A | Verfahren zur Reinigung von Heparin nach der Chromatographischen Methode |
-
1976
- 1976-03-05 SE SE7603040A patent/SE431218B/xx not_active IP Right Cessation
-
1977
- 1977-01-27 IL IL51346A patent/IL51346A/xx unknown
- 1977-02-14 CA CA271,731A patent/CA1079272A/en not_active Expired
- 1977-02-15 FI FI770491A patent/FI62103C/fi not_active IP Right Cessation
- 1977-02-22 NL NLAANVRAGE7701882,A patent/NL186385C/xx not_active IP Right Cessation
- 1977-02-23 ES ES456196A patent/ES456196A1/es not_active Expired
- 1977-02-25 JP JP2016477A patent/JPS52108012A/ja active Pending
- 1977-03-02 NZ NZ183480A patent/NZ183480A/xx unknown
- 1977-03-03 IE IE469/77A patent/IE44907B1/en not_active IP Right Cessation
- 1977-03-03 ZA ZA00771267A patent/ZA771267B/xx unknown
- 1977-03-04 SU SU772457090A patent/SU736860A3/ru active
- 1977-03-04 HU HU77KA1485A patent/HU176811B/hu unknown
- 1977-03-04 GB GB9275/77A patent/GB1539332A/en not_active Expired
- 1977-03-04 FR FR7706469A patent/FR2342991A1/fr active Granted
- 1977-03-04 AU AU22953/77A patent/AU508430B2/en not_active Expired
- 1977-03-04 DK DK096077A patent/DK155606C/da not_active IP Right Cessation
- 1977-03-04 AT AT144577A patent/AT356818B/de not_active IP Right Cessation
- 1977-03-04 NO NO770764A patent/NO144388C/no unknown
- 1977-03-04 PL PL1977196438A patent/PL103049B1/pl unknown
- 1977-03-04 DE DE2709500A patent/DE2709500C2/de not_active Expired
- 1977-03-07 CS CS771523A patent/CS196349B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2709500A1 (de) | 1977-09-08 |
| ATA144577A (de) | 1979-10-15 |
| NO144388C (no) | 1981-08-19 |
| IE44907L (en) | 1977-09-05 |
| FR2342991B1 (cs) | 1981-10-30 |
| NL7701882A (nl) | 1977-09-07 |
| GB1539332A (en) | 1979-01-31 |
| HU176811B (en) | 1981-05-28 |
| DK155606C (da) | 1989-09-11 |
| DE2709500C2 (de) | 1986-09-18 |
| IL51346A0 (en) | 1977-03-31 |
| JPS52108012A (en) | 1977-09-10 |
| ZA771267B (en) | 1978-01-25 |
| NO770764L (no) | 1977-09-06 |
| NZ183480A (en) | 1979-08-31 |
| ES456196A1 (es) | 1978-07-01 |
| NL186385B (nl) | 1990-06-18 |
| AU2295377A (en) | 1978-09-07 |
| AT356818B (de) | 1980-05-27 |
| DK96077A (da) | 1977-09-06 |
| IE44907B1 (en) | 1982-05-19 |
| AU508430B2 (en) | 1980-03-20 |
| DK155606B (da) | 1989-04-24 |
| PL103049B1 (pl) | 1979-05-31 |
| NO144388B (no) | 1981-05-11 |
| CS196349B2 (en) | 1980-03-31 |
| NL186385C (nl) | 1990-11-16 |
| CA1079272A (en) | 1980-06-10 |
| FR2342991A1 (fr) | 1977-09-30 |
| SE431218B (sv) | 1984-01-23 |
| IL51346A (en) | 1979-11-30 |
| FI62103B (fi) | 1982-07-30 |
| FI770491A7 (cs) | 1977-09-06 |
| SU736860A3 (ru) | 1980-05-25 |
| SE7603040L (sv) | 1977-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU621148B2 (en) | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography | |
| JP2929516B2 (ja) | 水性液体から腫瘍壊死因子または／およびリポ多糖を定量的、選択的に除去するかまたは／および調製的に製取する方法、液体から腫瘍壊死因子および／またはリポ多糖を体外除去する装置、装置ユニットおよび吸着材料 | |
| US4424206A (en) | Process for heat treatment of aqueous solution containing cold insoluble globulin to inactivate hepatitis virus | |
| FI60501B (fi) | Foerfarande foer selektiv separering av interferon fraon interferon-raopreparat | |
| EP0533946A1 (en) | Adsorbed cellular fibronectin and process for separating and purifying fibronectins | |
| CA2024667C (en) | Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma | |
| HU214905B (hu) | Eljárás VIII. faktor izolálására | |
| JP2009161547A (ja) | 高度に精製された第ｖｉｉｉ因子コンプレックス | |
| CA1240264A (en) | Covalently bound heparin-antithrombin iii complex | |
| DK147408B (da) | Fremgangsmaade til udvinding af thrombinagtige enzymer fra slangegifte eller slangegiftfraktioner | |
| CN106928344A (zh) | 用于从含有凝血因子的溶液中减少和/或除去FXI和FXIa的方法 | |
| FI62103C (fi) | Foerfarande foer framstaellning av heparin med hoeg specifik aktivitet | |
| JP2004511492A (ja) | ビクニンを含む血漿画分、その調製方法、およびその使用 | |
| Tager | Studies on the nature and the purification of the coagulase-reacting factor and its relation to prothrombin | |
| US4822872A (en) | Method of purifying factor VIII | |
| CA1283073C (en) | Adsorbent for purification of blood coagulation factor viii and process for purification of blood coagulation factor viii using the same | |
| US5681750A (en) | Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use | |
| JPH0153650B2 (cs) | ||
| JP2775093B2 (ja) | 免疫グロブリン含有組成物 | |
| Inose et al. | The elevation of plasma levels of myeloperoxidase and polymorphonuclear leukocyte elastase as an index of bioincompatibility of the column during hemodialysis using with a β2-microglobulin-selective adsorbent column | |
| JPS59167519A (ja) | 不活化トロンビンゲルにより血漿タンパク質混合液からフイブリノ−ゲンを除去する方法 | |
| JPS6237009B2 (cs) | ||
| JPH0566960B2 (cs) | ||
| JPS63198632A (ja) | 第８因子の製造方法 | |
| JPS63209750A (ja) | 血液凝固第８因子精製用吸着体およびそれを用いた血液凝固第８因子の精製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired | ||
| TC | Name/ company changed in patent |
Owner name: PHARMACIA AB |
|
| PC | Transfer of assignment of patent |
Owner name: PHARMACIA AB |
|
| MA | Patent expired |
Owner name: PHARMACIA AB |